Author(s): Syed Saif Imam

Email(s): saifbehappy@gmail.com

DOI: 10.52711/0974-360X.2024.00326   

Address: Syed Saif Imam*
Department of Hospital Management and Hospice Studies, Jamia, Millia Islamia, Jamia Nagar, Delhi.
*Corresponding Author

Published In:   Volume - 17,      Issue - 5,     Year - 2024


ABSTRACT:
Oral cancer is a malignant neoplasia which arises on the lip or oral cavity, due to this there can be increase in the inflammation and proliferation of cells of lip or oral cavity. Genistein, Cinnamaldehyde, Trans-Resveratrol and Formononetin possess potent anti-inflammatory and anti-cancerous potential. A sublingual formulation is prepared by combining above APIs with transfersomes and excipients like pullulan, sodium starch glycolate, mannitol, magnesium stearate, talc, Povidone k-30, Croscarmellose Na and mannose for quick and better pharmacological action with lesser side effects and higher permeability rate. This formulation easily penetrates the layers of oral cells and acts on cancerous cells of oral cavity by inhibiting pro-inflammatory cytokines LPS, TNFa, IL1, IL6, COX-2, LOX, oxidative stress, Bcl-2, Bax and lowers the metastasis of cells. It also downregulates KIF20A, ERK1/2, cIAP-2, survivin, cyclin D1, suppresses matrix metalloproteinase (MMP)-3, MMP-9, COX-2, VEGF and STAT3. Before preparation, the formulation will be tested on pre-compression parameters of powder which are angle of repose, bulk density, tap bulk density, Compressibility index and Hausner’s ratio. The tablets will be prepared by direct compression method and after preparation; the formulation will be tested on post-compression parameters which are tablet thickness, weight variation, and tablet hardness, tablet friability, wetting time, drug content uniformity, disintegration test, In-vitro drug release study and assay testing on RAW264.7 cell line. This formulation doesn’t produce any severe side effects and also it is much cheaper, expeditious and effective than traditional chemotherapies it is also non-invasive and lowers the chances of re-occurrence of cancer.


Cite this article:
Syed Saif Imam. Sublingual Tablets Amalgamated with Nano-particles and natural products to treat Oral Cancer. Research Journal of Pharmacy and Technology. 2024; 17(5):2056-2. doi: 10.52711/0974-360X.2024.00326

Cite(Electronic):
Syed Saif Imam. Sublingual Tablets Amalgamated with Nano-particles and natural products to treat Oral Cancer. Research Journal of Pharmacy and Technology. 2024; 17(5):2056-2. doi: 10.52711/0974-360X.2024.00326   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-5-22


REFERENCES:
1.    Rivera C. Essentials of oral cancer. International Journal of Clinical and Experimental Pathology. 2015; 8(9): 11884.
2.    Ghantous Y, Elnaaj A. Global incidence and risk factors of oral cancer. Harefuah. 2017 Oct 1; 156(10): 645-9.
3.    Mummudi N, Agarwal JP, Chatterjee S, Mallick I, Ghosh-Laskar S. Oral cavity cancer in the Indian subcontinent–challenges and opportunities. Clinical Oncology. 2019 Aug 1;31(8):520-8
4.    Dhanuthai K, Rojanawatsirivej S, Thosaporn W, Kintarak S, Subarnbhesaj A, Darling M, Kryshtalskyj E, Chiang CP, Shin HI, Choi SY, Lee SS. Oral cancer: A multicenter study. Medicina Oral, Patologia Oraly Cirugiabucal. 2018 Jan;23(1):e23.
5.    Bedi R, Scully C. Tropical oral health. Manson's Tropical Infectious Diseases. 2014:1073.Montero PH, Patel SG. Cancer of the oral cavity. Surgical Oncology Clinics. 2015 Jul 1; 24(3): 491-508.
6.    Nirmala V, Begu A. Effectiveness of video assisted teaching programme on prevention of oral cancer among tobacco chewers. Asian Journal of Nursing Education and Research. 2012 Apr 1; 2(2): IV.
7.    Gaikwad PS, Pimpodkar NV, Indalkar YR, Godase AS. Role of Dental and Healthcare Professionals in Preventing Oral Cancer. Asian Journal of Research in Pharmaceutical Science. 2015; 5(4): 239-46.
8.    Sharifi-Rad J, Quispe C, Imran M, Rauf A, Nadeem M, Gondal TA, Ahmad B, Atif M, Mubarak MS, Sytar O, Zhilina OM. Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits. Oxidative Medicine and Cellular Longevity. 2021 Jul 19;2021.
9.    Lepri SR, Zanelatto LC, da Silva PB, Sartori D, Ribeiro LR, Mantovani MS. The effects of genistein and daidzein on cell proliferation kinetics in HT29 colon cancer cells: the expression of CTNNBIP1 (β-catenin), APC (adenomatous polyposis coli) and BIRC5 (survivin). Human Cell. 2014 Apr; 27(2): 78-84.
10.    Spagnuolo C, Russo GL, Orhan IE, Habtemariam S, Daglia M, Sureda A, Nabavi SF, Devi KP, Loizzo MR, Tundis R, Nabavi SM. Genistein and cancer: current status, challenges, and future directions. Advances in Nutrition. 2015 Jul;6(4):408-19.
11.    Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. Apoptosis of human primary gastric carcinoma cells induced by genistein. World Journal of Gastroenterology: WJG. 2004 Jun 15;10(12):1822.
12.    Yan GR, Zou FY, Dang BL, Zhang Y, Yu G, Liu X, He QY. Genistein‐induced mitotic arrest of gastric cancer cells by downregulating KIF 20 A, a proteomics study. Proteomics. 2012 Aug;12(14):2391-9.
13.    Wang SD, Chen BC, Kao ST, Liu CJ, Yeh CC. Genistein inhibits tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. BMC Complementary and Alternative Medicine. 2014 Dec; 14(1): 1-2.
14.    Li J, Li J, Yue Y, Hu Y, Cheng W, Liu R, Pan X, Zhang P. Genistein suppresses tumor necrosis factor α-induced inflammation via modulating reactive oxygen species/Akt/nuclear factor κB and adenosine monophosphate-activated protein kinase signal pathways in human synoviocyte MH7A cells. Drug Design, Development and Therapy. 2014;8:315.
15.    Ray RC, Haque MM, Alim A, Alam M, Ali S, Mannan MA, Farooque A. Synthesis and Characterization with Antimicrobial activity of Cu (II), Ni (II) and Zn (II) metal complexes of Schiff base derived from o-aminophenol/ethylenediamine and Cinnamaldehyde. Asian Journal of Research in Chemistry. 2015; 8(9): 571-3.
16.    Rao PV. Gan SH. Cinnamon: a multifaceted medicinal plant. Evidence-Based Complementary and Alternative Medicine. 2014.
17.    Soufli I. Toumi R. Rafa H. Touil-Boukoffa C. Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases. World Journal of Gastrointestinal Pharmacology and Therapeutics. 2016; 7(3): 353.
18.    Chao LK. Hua KF. Hsu HY. Cheng SS. Lin IF. Chen CJ. Chen ST. Chang ST. Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling. Food and Chemical Toxicology. 2008; 46(1):220-31.
19.    Kim NY. Trinh NT. Ahn SG. Kim SA. Cinnamaldehyde protects against oxidative stress and inhibits the TNF α induced inflammatory response in human umbilical vein endothelial cells. International Journal of Molecular Medicine. 2020; 46(1):449-457.
20.    Pannee C. Chandhanee I. Wacharee L. Antiinflammatory effects of essential oil from the leaves of Cinnamomum cassia and cinnamaldehyde on lipopolysaccharide-stimulated J774A. 1 cells. Journal of Advanced Pharmaceutical Technology & Research. 2014; 5(4):164
21.    Wu SJ, Ng LT, Lin CC. Cinnamaldehyde-induced apoptosis in human PLC/PRF/5 cells through activation of the proapoptotic Bcl-2 family proteins and MAPK pathway. Life Sciences. 2005 Jul 8;77(8):938-51.
22.    Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, Fokou PV, Martins N, Sharifi-Rad J. Resveratrol: A double-edged sword in health benefits. Biomedicines. 2018 Sep; 6(3): 91.
23.    Gianchecchi E, Fierabracci A. Insights on the effects of resveratrol and some of its derivatives in cancer and autoimmunity: a molecule with a dual activity. Antioxidants. 2020 Feb; 9(2): 91
24.    Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS. The role of resveratrol in cancer therapy. International journal of Molecular Sciences. 2017 Dec; 18(12): 2589.
25.    Kanduja KL, Hardwaj A, Kaushik G. Resveratrol inhibits N-nitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice. Journal of Nutritional Science and Vitaminology. 2004; 50(1): 61-5.
26.    Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Archives of Biochemistry and Biophysics. 2009 Jun 15; 486(2): 95-102.
27.    Kotha A, Sekharam M, Cilenti L, Siddiquee K, Khaled A, Zervos AS, Carter B, Turkson J, Jove R. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Molecular Cancer Therapeutics. 2006 Mar 1; 5(3): 621-9.
28.    Chang CC, Chang CY, Huang JP, Hung LM. Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin-induced type 1 diabetic rats. Chin J Physiol. 2012 Jun 30; 55(3): 192-201.
29.    Jiang D, Rasul A, Batool R, Sarfraz I, Hussain G, Mateen Tahir M, Qin T, Selamoglu Z, Ali M, Li J, Li X. Potential anticancer properties and mechanisms of action of formononetin. BioMed Research International. 2019 Jul 28; 2019.
30.    Wang W, Tanaka Y, Han Z, Higuchi CM. Proliferative response of mammary glandular Tissue to Formononetin.1995: 131-140.
31.    Wang Y, Zhu Y, Gao L, Yin H, Xie Z, Wang D, Zhu Z, Han X. Formononetin attenuates IL-1β-induced apoptosis and NF-κB activation in INS-1 cells. Molecules. 2012 Sep;17(9):10052-64
32.    Liu Y, He J, Chen X, Li J, Shen M, Yu W, Yang Y, Xiao Z. The proapoptotic effect of formononetin in human osteosarcoma cells: involvement of inactivation of ERK and Akt pathways. Cellular Physiology and Biochemistry. 2014;34(3):637-45.
33.    Kim MS, Park JS, Chung YC, Jang S, Hyun CG, Kim SY. Anti-inflammatory effects of formononetin 7-O-phosphate, a novel biorenovation product, on LPS-Stimulated RAW 264.7 macrophage cells. Molecules. 2019 Jan;24(21):3910.
34.    Huang J, Chen X, Xie A. Formononetin ameliorates IL‑13‑induced inflammation and mucus formation in human nasal epithelial cells by activating the SIRT1/Nrf2 signaling pathway. Molecular Medicine Reports. 2021 Dec 1;24(6):1-9.
35.    Modi CD, Bharadia PD. Transfersomes: new dominants for transdermal drug delivery. Am J Pharm Tech Res. 2012; 2(3): 71-91.
36.    Opatha SA, Titapiwatanakun V, Chutoprapat R. Transfersomes: A promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics. 2020 Sep; 12(9): 855.
37.    Anusha V. Transferosomes-A Novel Vesicular System. Research Journal of Pharmaceutical Dosage Forms and Technology. 2014; 6(4): 286-91.
38.    Gupta R, Singhal M. Transferosomes as an efficient carrier system for better therapeutic response of targeted drug delivery system. Research Journal of Pharmacy and Technology. 2022; 15(2): 913-20.
39.    Thulluru A, Mahammed N, Madhavi C, Nandini K, Sirisha S, Spandana D. Sublingual Tablets-An Updated Review. Asian Journal of Pharmaceutical Research. 2019; 9(2): 97-103.
40.    Sarkhejiya NA, Khachar KK, Patel VP. Formulation Development and Evaluation of Sublingual Tablet of Risperidone. Research Journal of Pharmacy and Technology. 2013; 6(4): 428-34.
41.    Panda KC, Reddy AV, Panda N, Shamim MD, Habibuddin M, Jayaveera KN. Formulation and evaluation of vilazodone sublingual tablets by using lyophilization technique. Research Journal of Pharmacy and Technology. 2018; 11(1): 267-74.
42.    Bose S, Kim H. Evaluation of in vitro anti-inflammatory activities and protective effect of fermented preparations of Rhizoma Atractylodis Macrocephalae on intestinal barrier function against lipopolysaccharide insult. Evidence-Based Complementary and Alternative Medicine. 2013 Jan 1; 2013.
43.    Vidhya RU, Prabhu MN, Bhuminathan S. Review on anticancer properties of piperine in oral cancer: Therapeutic perspectives. Research Journal of Pharmacy and Technology. 2022; 15(7): 3338-42.
44.    Imam ST, Imam SS. The Cream which relieves the pain of Menstrual cramps without interfering with the Hormones or Period Cycle. Research Journal of Pharmacy and Technology. 2023; 16(3).
45.    Imam SS, Agarwal S. A pragmatic approach to treat lung cancer through loading theaflavin -3,3’-digallate and epigallocatechin gallate in spanlastic. Asian J Pharm Clin Res. 2021 Nov. 7; 14(11): 1-8.
46.    Imam SS, Imam ST, Mdwasifathar, Kumar R, Ammar MY. Interaction between ace 2 and sars-cov2, and use of egcg and theaflavin to treat covid 19 in initial phases. Int J Curr Pharm Sci. 2022 Mar. 15; 14(2): 5-10.
47.    Imam SS, Imam ST, Agarwal S, Kumar R, Ammar MY, Athar MW, Akhtar A. Lung cancer therapy using naturally occurring products and nanotechnology. Innovare J Med Sci. 2022 Jun; 10(4): 1-5.
48.    Sharma S, kumari D, khan S, Pathak P, Katiyar D, Imam SS. An expedient approach to treat asthma through non-steroidal, natural transferosomes aerosol system. Innovare J Med Sci. 2022 Oct. 25; 10(6): 7-11.
49.    Imam SS. The future of non-invasive ways to treat cancer. International Journal of Pharmaceutical Sciences and Research. 2021; 12(9): 4684-96.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available